Patent classifications
C07F15/025
NEW METAL N-AMINOGUANIDINATE COMPLEXES FOR USE IN THIN FILM FABRICATION AND CATALYSIS
The present patent application relates to new metal complexes having at least one N-aminoguanidinate ligand. The patent application further relates to the preparation of the new metal complexes and also to their use. The new metal complexes are especially suitable as precursors for the preparation of functional layers by means of gas-phase thin-film processes such as CVD, MO-CVD, MOVPE and ALD. Additionally, they are also suitable as catalysts for olefin hydroamination and for olefm polymerization.
##STR00001##
CRYSTALLINE FORMS OF FERRIC MALTOL
There is provided polymorphs of ferric maltol. Such forms may be useful in the treatment of iron deficiency with or without anaemia, such as iron deficiency anaemia.
Synthesis and characterization of first row transition metal complexes containing α-imino alkoxides as precursors for deposition of metal films
A compound that is useful for forming a metal by reaction with a reducing agent is described by formula (I): ##STR00001##
wherein M is a metal selected from Groups 2 through 12 of the Periodic Table; and R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are each independently H or C.sub.1-C.sub.8 alkyl.
METHOD FOR FORMING A METAL-ORGANIC FRAMEWORK
A method for forming a metal-organic framework comprising a step of providing a substrate; a single step of forming a single layer of metal oxide formed on the substrate said layer of metal oxide being transformed in whole or in part into metal-organic framework by successive implementation of a plurality of reaction cycles; each reaction cycle of the plurality of reaction cycles comprising: a treatment step with at least one ligand; a treatment step with at least one additive; the reaction cycles being implemented at least twice so as to form the metal-organic framework on the substrate.
Organometallic precursor compound for vapor deposition for forming oxide thin film and method for manufacturing same
An organometallic compound, which enables thin-film deposition through vapor deposition, and particularly to a Co or Fe precursor, which is suitable for use in atomic layer deposition or chemical vapor deposition, and a method of preparing the same.
COMPOUND, COMPLEX, PREPARATION METHOD THEREOF, AND USE THEREOF
The present disclosure provides a compound, a complex, a preparation method thereof, and a use thereof. The compound is represented by the following structural formula, in which R.sup.1 to R.sup.10 are the same or different and are each independently selected from hydrogen, a hydrocarbon group having a carbon number of C.sub.1 to C.sub.16, a substituted hydrocarbon group, an alkoxy group, an alkylthio group, an alkylamino group, a haloalkylthio group, a halogen-substituted alkoxy group, a halogen-substituted alkylamino group, an aryloxy group, an arylthio group, arylamino group, a diphenylphosphino group, a halogen group, a nitro group, or a nitrile group. The complex of one embodiment of the present disclosure has a high catalytic effect, and can be used to prepare a highly branched, controllable, low molecular weight polymer with a high activity.
##STR00001##
COMPOUNDS FOR MODULATION AND AS FUNCTIONAL REPLACEMENT OF ALPHAKETOGLUTARIC ACID (2OG)-DEPENDENT OXYGENASES
The present invention relates to an alternative co-substrate of ketoglutaric acid-dependent dioxygenases for functional production and control of same, with the aim of achieving therapeutic effects against cancer, neurodegenerative diseases and age related diseases. Epigenetically induced diseases caused by dysregulation and in particular also by metabolic dysfunction in the citric acid cycle are likewise targeted by this therapy.
Syntheses and Uses of Tri-Substituted Mono-Hydrogen Ferrocyanides for Efficient Hydroxyl Radical Generators
Embodiments of the present invention provide for syntheses and uses of tri-substituted mono-hydrogen ferrocyanides for efficient hydroxyl radical generators. For example, the present invention provides for the syntheses of mono-hydrogen ferrocyanides of the general formula M.sub.3HFe(CN).sub.6 in which iron has an oxidation number of +2 (ferro) and the positive counter-ion, M, belongs mainly to the group of the alkali metals such as Na+, K+ and Li+, or to organic alkyl cations such as imidazole derivatives.
Compounds for use as iron (III) MRI contrast agents containing anionic pendents and ancillary groups
Macrocyclic complexes and macrocyclic compounds. The macrocyclic complexes or macrocyclic compounds have a TACN moiety with one or more amine group(s) or a O- or S-substituted TACN moiety. The macrocyclic complexes have a high-spin Fe(III) atom coordinated to the TACN moiety. The macrocyclic complexes can be used in imaging methods.
Production And Use Of Metal Organic Frameworks
A process for producing a bimetallic, terephthalate metal organic framework (MOF) having a flexible structure and comprising aluminum and iron cations, comprises contacting a water-soluble aluminum salt, a chelated iron compound and 1,4-benzenedicarboxylic acid or a salt thereof with a fluoride-free mixture of water and a polar organic solvent at a reaction temperature of less than 200° C. to produce a solid reaction product comprising the MOF.